Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Evaluation of sexual function in women at two stages of multiple sclerosis.
MRI in multiple sclerosis: a review of the current literature.
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
[Optical coherence tomography in multiple sclerosis].
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS.
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.
The ketogenic diet as a treatment paradigm for diverse neurological disorders.
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
A biopsychosocial model of resilience for multiple sclerosis.
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
Corticosteroids for treating optic neuritis.

Pages